The Latest in Multiple Myeloma

Hematology News

Study finds no standard for treatment discontinuation in myeloma

October 1, 2019

Hematology News

Second-generation anti-BCMA CAR T-cell therapy shows promise in myeloma trial

September 27, 2019

Hematology News

Daratumumab approved in combo with VTd for transplant-eligible multiple myeloma

September 26, 2019

Hematology News

Subcutaneous and IV daratumumab combos appear comparable in myeloma

September 26, 2019

Hematology News

Quadruplet prolongs progression-free survival in newly diagnosed myeloma

September 26, 2019

Hematology News

Oral triplet shows promise for relapsed/refractory myeloma

September 22, 2019

Hematology News

Combo could be new standard for transplant-eligible, newly diagnosed myeloma patients

September 20, 2019

Hematology News

Adding elotuzumab to lenalidomide/dexamethasone can prolong survival in relapsed/refractory myeloma

September 19, 2019

Hematology News

CT103A elicits responses after prior CAR T-cell relapse

September 19, 2019

Hematology News

Melflufen-dexamethasone active in patients with relapsed/refractory myeloma and EMD

September 19, 2019

Hematology News

VRD pretransplant induction deepens responses in myeloma

September 17, 2019

Hematology News

Progressive myeloma after induction? Go straight to transplant

September 6, 2019

Hematology News

Combo produces responses in triple-class refractory myeloma

August 21, 2019

Hematology News

Cardiovascular complications most common with carfilzomib in relapsed myeloma

August 9, 2019

Hematology News

TP53 double hit predicts aggressive myeloma

July 31, 2019